Targeting interleukin-23 in the treatment of noninfectious uveitis

KL Pepple, P Lin - Ophthalmology, 2018 - Elsevier
The interleukin (IL)-23/IL-17 axis plays a central role in the pathogenesis of immune-
mediated diseases such as psoriasis, psoriatic arthritis, Crohn's disease, and uveitis …

Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis

Z Zhong, G Su, A Kijlstra, P Yang - Progress in retinal and eye research, 2021 - Elsevier
Uveitis is a group of diseases characterized by intraocular inflammation, of which some are
driven by autoinflammatory or autoimmune responses, such as Vogt-Koyanagi-Harada …

Targeting interleukin-6 in autoimmune uveitis

M Mesquida, B Molins, V Llorenç, MS de la Maza… - Autoimmunity …, 2017 - Elsevier
Abstract Interleukin-6 (IL-6) is a key cytokine that is strongly up-regulated during infection
and inflammation. Featuring pleiotropic activity, IL-6 is responsible for the induction of …

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis

W Hueber, DD Patel, T Dryja, AM Wright… - Science translational …, 2010 - science.org
Interleukin-17A (IL-17A) is elaborated by the T helper 17 (TH17) subset of TH cells and
exhibits potent proinflammatory properties in animal models of autoimmunity, including …

[HTML][HTML] Roles of interleukin-17 in uveitis

MCE Guedes, LM Borrego… - Indian journal of …, 2016 - journals.lww.com
Abstract Th17 cells, a CD4+ T-cell subset, produce interleukin (IL)-17, a pro-inflammatory
cytokine that has been shown to be involved in several forms of infectious and noninfectious …

Interleukin-6 blockade in ocular inflammatory diseases

M Mesquida, A Leszczynska, V Llorenç… - Clinical & …, 2014 - academic.oup.com
Summary Interleukin-6 (IL-6) is a key cytokine featuring redundancy and pleiotropic activity.
It plays a central role in host defence against environmental stress such as infection and …

Targeting interleukin-6 for noninfectious uveitis

P Lin - Clinical Ophthalmology, 2015 - Taylor & Francis
Interleukin-6 (IL-6) is a pleiotropic cytokine implicated in the pathogenesis of many immune-
mediated disorders including several types of non-infectious uveitis. These uveitic …

Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses

M Cordero-Coma, S Calleja, M Llorente… - Ocular Immunology …, 2013 - Taylor & Francis
Purpose: To report the effect of adalimumab on serum cytokines in chronic refractory uveitis.
Methods: Prospective study on the effects of adalimumab on serum cytokine levels at …

Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis

T Yoshimura, KH Sonoda, N Ohguro, Y Ohsugi… - …, 2009 - academic.oup.com
Objectives. Human endogenous uveitis is one of the sight-threatening diseases associated
with variety of systemic disorders, such as Behcet's disease and sarcoidosis. Recently …

[HTML][HTML] Interleukin-6 inhibition in the management of non-infectious uveitis and beyond

S Karkhur, M Hasanreisoglu, E Vigil, MS Halim… - Journal of ophthalmic …, 2019 - Springer
Background Uveitis consists of a spectrum of inflammatory disorders characterized by ocular
inflammation. The underlying pathophysiology consists of a complex interplay of various …